SUTRO BIOPHARMA, INC. Quarterly Current Ratio in % from Q2 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Sutro Biopharma, Inc. quarterly Current Ratio history and growth rate from Q2 2019 to Q2 2024.
  • Sutro Biopharma, Inc. Current Ratio for the quarter ending June 30, 2024 was 425 %, a 24.6% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 425 -138 -24.6% Jun 30, 2024
Q1 2024 500 -83.5 -14.3% Mar 31, 2024
Q4 2023 517 -88.6 -14.6% Dec 31, 2023
Q3 2023 544 -70 -11.4% Sep 30, 2023
Q2 2023 563 -78.3 -12.2% Jun 30, 2023
Q1 2023 583 -103 -15% Mar 31, 2023
Q4 2022 605 -199 -24.7% Dec 31, 2022
Q3 2022 614 -416 -40.4% Sep 30, 2022
Q2 2022 641 -480 -42.8% Jun 30, 2022
Q1 2022 687 -329 -32.4% Mar 31, 2022
Q4 2021 804 -28 -3.36% Dec 31, 2021
Q3 2021 1.03K +411 +66.4% Sep 30, 2021
Q2 2021 1.12K +644 +135% Jun 30, 2021
Q1 2021 1.02K +611 +151% Mar 31, 2021
Q4 2020 832 +389 +87.8% Dec 31, 2020
Q3 2020 619 +129 +26.2% Sep 30, 2020
Q2 2020 477 -4.03 -0.84% Jun 30, 2020
Q1 2020 404 Mar 31, 2020
Q4 2019 443 Dec 31, 2019
Q3 2019 490 Sep 30, 2019
Q2 2019 481 Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.